Key Insights

Highlights

Treatment Research

3 treatments under study, led by Essential Amino Acids Plus Arginine

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Withdrawn1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07402382Not ApplicableRecruiting

Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women

NCT02337894Not ApplicableWithdrawn

Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children

Showing all 2 trials

Research Network

Common Treatments

  • Essential Amino Acids Plus Arginine1
  • Concentrated Amylopectinchromium Blend1
  • Amylopectinchromium Blend1

Active Sponsors

  • Nutrition 21, Inc.1
  • The Center for Applied Health Sciences, LLC1
  • Arkansas Children's Hospital Research Institute1

Top Investigators

Related Conditions

  • Postmenopause1
  • Glucose Monitoring Continuous1
  • Perimenopausal Women1
  • Body Composition Beneficial1
  • Insulin Resistance1

Activity Timeline